(Q40098479)

17 September 2017

title

Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers (English)

1 reference

17 September 2017

Masanobu Sato

1

1 reference

17 September 2017

Takashi Iwanaga

2

1 reference

17 September 2017

Hideaki Mamada

3

1 reference

17 September 2017

Toshio Ogihara

4

1 reference

17 September 2017

Hikaru Yabuuchi

5

1 reference

17 September 2017

Tomoji Maeda

6

1 reference

17 September 2017

Ikumi Tamai

7

1 reference

17 September 2017

publication date

3 August 2007

1 reference

17 September 2017

published in

Pharmaceutical Research

1 reference

17 September 2017

volume

25

1 reference

17 September 2017

issue

3

1 reference

17 September 2017

page(s)

639-646

1 reference

Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension

17 September 2017

cites work

1 reference

12 December 2020

[Tissue distribution of the multidrug-resistance gene product P-glycoprotein and its physiological function]

1 reference

12 December 2020

Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.

1 reference

12 December 2020

Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane

1 reference

12 December 2020

Inhibitory effects of angiotensin II receptor antagonists and leukotriene receptor antagonists on the transport of human organic anion transporter 4.

1 reference

12 December 2020

Concentration-dependent mode of interaction of angiotensin II receptor blockers with uric acid transporter.

1 reference

12 December 2020

Urate transport via human PAH transporter hOAT1 and its gene structure

1 reference

12 December 2020

Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney

1 reference

12 December 2020

Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study

1 reference

12 December 2020

The development of allopurinol

1 reference

12 December 2020

Characterization of hepatobiliary transport systems of a novel alpha4beta1/alpha4beta7 dual antagonist, TR-14035.

1 reference

12 December 2020

Effects of losartan on renal function in patients with essential hypertension

1 reference

12 December 2020

Molecular physiology of urate transport

1 reference

12 December 2020

Molecular identification of a renal urate anion exchanger that regulates blood urate levels

1 reference

12 December 2020

Transport of the dopamine D2 agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney

1 reference

12 December 2020

p-aminohippuric acid transport at renal apical membrane mediated by human inorganic phosphate transporter NPT1.

1 reference

12 December 2020

Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites.

1 reference

12 December 2020

Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance

1 reference

12 December 2020

Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone.

1 reference

12 December 2020

Pilot study of the uricosuric effect of DuP-753, a new angiotensin II receptor antagonist, in healthy subjects

1 reference

12 December 2020

Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial

1 reference

12 December 2020

Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects

1 reference

12 December 2020

Human renal organic anion transporter 4 operates as an asymmetric urate transporter

1 reference

12 December 2020

Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney

1 reference

12 December 2020

Serum uric acid and cardiovascular events in successfully treated hypertensive patients

1 reference

12 December 2020

10.1007/S11095-007-9401-6

Identifiers

DOI

1 reference

17 September 2017

1 reference